Key Highlights

  • Haoxi Health Technology (NASDAQ:HAO) traded at USD 1.70, down 13.27%, in pre-market trading on Tuesday, October 27, 2026, after a 1-for-128 reverse share split effective Thursday, May 21, 2026 and a 1-for-20 split on Friday, August 14, 2026.
  • Lion Group Holding (NASDAQ:LGHL) traded at USD 2.26, down 9.22%; the release of Wednesday, September 30, 2026 put holdings of Hyperliquid (HYPE) tokens at about 232,900, valued at about USD 20.1 million.
  • Nauticus Robotics (NASDAQ:KITT) traded at USD 1.23, down 6.11%, with cash, cash equivalents and restricted cash of USD 1,977,049 at June 30, 2026, against USD 7,616,952 at December 31, 2025.
  • INVO Fertility (NASDAQ:IVF) traded at USD 0.5359, down 5.98%, with a quarterly adjusted EBITDA loss of USD 1,032,660. No company-specific announcement dated on or just before the session accompanied any of the four moves.

Haoxi Health Technology (NASDAQ:HAO): an overhang of splits and offerings

Haoxi Health Technology (NASDAQ:HAO), a China-based company that provides digital marketing and livestreaming services, has its most recent release dated Wednesday, August 12, 2026. That release announced a 1-for-20 reverse share split, which reduced Class A ordinary shares from 11,904,632 to about 595,232. The decline appears consistent with thin liquidity and with the dilution pattern of recent months, which is an inference, and a share count this small can amplify price swings.

The company announced registered direct offerings of USD 6.5 million at USD 0.25 per share on Monday, May 11, 2026 and of USD 4 million at USD 0.40 per share on Friday, July 10, 2026, both priced before the splits. The annual report on Form 20-F filed on Wednesday, September 30, 2026 shows revenue of about USD 54.83 million, up 67.1%, and a net loss of about USD 9.54 million against net income of about USD 3.9 million a year earlier. Cash was about USD 11 million, against about USD 8.6 million. These figures are rounded, and the reporting currency is taken to be USD. The bull reading rests on revenue growth and cash. The bear reading rests on the swing to a loss, two splits in one year and minimum bid price non-compliance below USD 1.00.

Lion Group Holding (NASDAQ:LGHL): a concentrated treasury and a court process

Lion Group Holding (NASDAQ:LGHL), a financial services company whose recent releases centre on a digital asset treasury and the restructuring of Skyfame Realty, has its most recent release dated Wednesday, September 30, 2026. It stated that the company had sold all Solana and part of its Bitcoin on Tuesday, September 29, 2026 and bought about 38,102 HYPE tokens. The decline appears consistent with thin liquidity and with the price sensitivity of a treasury concentrated in one digital asset, which is an inference.

Earlier releases gave holdings of about 195,000 tokens, valued at about USD 15.8 million on Monday, August 24, 2026, and a value of about USD 18.2 million on Monday, September 21, 2026. Market data show fiscal 2025 revenue of USD 7.26 million and a net loss of USD 4.96 million. The depositary share ratio changed to 5,850,000 Class A shares per ADS, about one-for-twenty, on or about Thursday, September 10, 2026, after a one-for-nine change in July 2026. For Skyfame, a court allowed a scheme creditors' meeting, expected in late October or early November 2026, with a tentative sanction hearing on Friday, November 20, 2026. The scheme carries no assurance of completion.

Nauticus Robotics (NASDAQ:KITT): funding by issuance

Nauticus Robotics (NASDAQ:KITT), a Houston-based developer of autonomous subsea robots and related software, declined in a way that appears consistent with thin pre-market liquidity and with the pattern typical of micro-cap stocks that fund operations through share issuance, rather than with a discrete corporate event. The most recent formal disclosure was the earnings release of Wednesday, August 12, 2026. The company completed a 1-for-8 reverse split on Tuesday, April 21, 2026, after a 1-for-9 split in 2025.

That release reported revenue of USD 885,947 for the quarter ended June 30, 2026, against USD 2,075,566 a year earlier, and an operating loss of USD 6,008,392. The net loss was USD 11,115,972, or USD 2.30 per share, which included a loss on extinguishment of debt of USD 4,629,822. Updates included the commercial release of the ToolKITT tool and a completed first scope of work in a multiphase defence opportunity, with no numeric guidance or backlog figure. The bull reading rests on a possible defence award. The bear reading rests on a small cash balance, dilution from at-the-market sales and revenue concentration in a few offshore projects.

INVO Fertility (NASDAQ:IVF): a reported profit built on a non-cash gain

INVO Fertility (NASDAQ:IVF), an operator of fertility clinics and a provider of an intravaginal culture device for in vitro fertilisation, declined in a pattern that appears consistent with thin pre-market liquidity and with the volatility of a micro-cap stock priced below USD 1.00. The most recent formal disclosure was the release of Monday, August 17, 2026, which covered the second quarter of 2026. A 1-for-5 reverse split took effect on Friday, March 27, 2026.

Revenue was USD 2,175,485 for the quarter ended June 30, 2026, up 17% from USD 1,863,654. Net income was USD 888,740 against a net loss of USD 3,618,969 a year earlier, but the result included a USD 2,452,032 non-cash gain on remeasurement tied to the Birmingham, Alabama clinic. Adjusted EBITDA, a non-GAAP measure of operating earnings, was a wider loss than the USD 587,229 of a year earlier, and cash was USD 3.7 million. The bull reading rests on the Family Beginnings clinic in Indiana, acquired in February 2026, and full ownership of Birmingham. The bear reading rests on the non-recurring gain and the Nasdaq late-filing notices disclosed for the Form 10-K and a Form 10-Q.

Where Things Stand

The answer is that thin liquidity set the direction of all four declines, while the overhang explains why each stock was vulnerable. Haoxi Health Technology (NASDAQ:HAO) carries a record of two splits and two offerings, Lion Group Holding (NASDAQ:LGHL) a treasury tied to one token and a court-supervised scheme, Nauticus Robotics (NASDAQ:KITT) a funding need that issuance has met, and INVO Fertility (NASDAQ:IVF) a profit that depends on a non-cash gain.

The next catalysts are the Federal Reserve decision on Wednesday, October 28, 2026, which follows the rate rise to 4.00% from 3.75% on Wednesday, September 16, 2026, the Skyfame creditors' meeting in late October or early November 2026, the sanction hearing tentatively set for Friday, November 20, 2026 and the third-quarter results of Nauticus Robotics and INVO Fertility. Pre-market prices are thinly traded snapshots and can change before the open at 9:30 a.m. ET, and this is not investment advice.